PATIENT SUPPORT AS UNIQUE AS YOU

Personalized, streamlined treatment
resources and support from
BIMZELX Navigate™

Join now

Member Login
BIMZELX® Copay option

From the first dose,
eligible commercially insured
patients pay $15 or less*

BIMZELX® Nurse Navigator

A dedicated Nurse Navigator
by your side from day 1†

Online home for BIMZELX® tools and information.

An online home for
tools and information

From the moment you receive your prescription, BIMZELX Navigate is here for you—tailored patient support that's designed to be easy to use and available whenever you need it.

BIMZELX® Copay Support.
BIMZELX savings  : help getting started

We know starting or switching biologics can be complicated, even after you've been prescribed by your healthcare provider.

  • We’ll ship BIMZELX to eligible patients with employer-provided or private insurance for $15 per dose for up to 2 years, if coverage is delayed or denied by your insurance.*
  • If your insurance approves BIMZELX when you're first prescribed, eligible patients will start and stay at $5 per dose.
  • We know that prescription drug pricing can be confusing. If you have questions about BIMZELX affordability, your Nurse Navigator can help.† For detailed BIMZELX pricing information click here or contact your insurance provider.
BIMZELX® Nurse Navigator.
NURSE NAVIGATOR:
A SINGLE,
COMPASSIONATE POINT OF
connection

When you enroll, you’ll be paired with a dedicated Nurse Navigator—one person you can rely on to connect you to everything BIMZELX Navigate has to offer. They’ll answer your questions, keep you up-to-date about your prescription and insurance status, and discuss your treatment goals.†

My Navigate
MY NAVIGATE:
AN ONLINE RESOURCE TO KEEP YOUR TREATMENT moving forward

Stay focused on your treatment goals with tools and online resources.

  • Track medication shipments and insurance status
  • Stay in touch with your Nurse Navigator†
  • Find injection resources
  • Set up medication reminders and sharps disposal
  • For eligible commercially insured patients only. Eligible patients may pay as little as $15 per dose of BIMZELX® for up to two years or until the patient’s commercial insurance plan approves coverage, whichever comes first. View complete eligibility requirements and terms.
  • 10.1.1

Join BIMZELX Navigate today

Enroll now
Patient Assistance Program

UCB, the maker of BIMZELX, remains committed to helping moderate to severe plaque psoriasis patients gain access to the medicines we manufacture. The UCB Patient Assistance Program may be able to help if you do not have health insurance or if you otherwise cannot afford your medication.

The UCB Patient Assistance Program may provide medication at no cost to eligible patients who are unable to pay for their BIMZELX prescription. 

To find out if you might be eligible for assistance, or to learn more about the UCB Patient Assistance Program, contact UCBCares® at 1-844-599-CARE (2273).

Once enrolled in the UCB Patient Assistance Program you can join BIMZELX Navigate where you'll have access to patient support offerings including a Nurse Navigator, injection training, medication reminders, and more.

Get started by reviewing the program instructions and filling out the application form.

PROGRAM INSTRUCTIONS AND APPLICATION FORM
UCB Cares About People

UCBCares® is the hub for information on all UCB products. Reach out to our team of nurses, pharmacists, and customer service professionals to:

  • Ask questions about UCB products
  • Report side effects or product quality concerns
  • Get clinical trial information and support
  • Find information on affording your UCB medication

Connect With Us

1-844-599-CARE (2273)
www.askucbcares.com

BIMZELX Bridge: Eligible patients must be 18 years of age or older with commercial insurance and a valid prescription consistent with FDA-approved product labeling for BIMZELX® (bimekizumab-bkzx). Eligible patients may pay as little as $15 per dose of BIMZELX for up to two years or until the patient’s commercial insurance plan approves coverage for the drug, whichever comes first. Program is not available (1) to patients whose prescriptions are reimbursed, in whole or in part, under Medicare (including Medicare Part D), Medicaid, or any other federal- or state-funded health care programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico), (2) where a patient’s insurance covers the drug, (3) to uninsured or cash-paying patients, or (4) where otherwise prohibited by law. Product shall be dispensed pursuant to program rules and federal and state laws. Patients may be asked to re-verify insurance coverage status during participation in the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. This program cannot be combined with any other savings, free trial, or similar offer for the specified prescription. The patient, or healthcare provider on the patient’s behalf, must not submit any claim for reimbursement for product provided under this program to any third-party payer. UCB reserves the right to end or amend this program without notice.
For initial enrollment into the program, the patient must be experiencing a delay in, or have been denied, coverage for BIMZELX by their commercial insurance plan. To maintain eligibility in the program, the following are required: (1) a prior authorization request has been submitted and/or coverage remains unavailable for the patient; and (2) if the prior authorization is denied by the payer, the prescriber must submit an appeal within the first sixty (60) days of the prior authorization denial and a prior authorization must be submitted every six (6) months thereafter or documentation as may otherwise be required by the payer.

BIMZELX Savings:  Eligible patients may pay $5 per dose. Available to individuals 18 years of age or older with commercial insurance coverage with a valid prescription consistent with FDA-approved product labeling for BIMZELX® (bimekizumab-bkzx). Not valid (1) for prescriptions that are reimbursed, in whole or in part, under Medicare (including Medicare Part D), Medicaid, or any other federal- or state-funded healthcare programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico), (2) where a patient’s commercial insurance plan reimburses for the entire cost of the drug, (3) for uninsured or cash paying patients, or (4) where otherwise prohibited by law. Product shall be dispensed pursuant to program rules and federal and state laws. The value of the program is exclusively for the benefit of patients and is intended to be credited in full towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance and deductibles. Patient may not seek reimbursement for the value of this program from other parties, including third-party payers (ie, any health insurance program or plan, or public payers like Medicare, Medicaid, Medigap, TRICARE, VA, and DoD). Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the program. This program cannot be combined with any other savings, free trial, or similar offer for the specified prescription. UCB reserves the right to amend or end this program at any time without notice.

icons/feathericon/arrow-up-circle

IMPORTANT SAFETY INFORMATION:
What is the most important information I should know about BIMZELX® (bimekizumab-bkzx)?
BIMZELX is a medicine that affects your immune system. BIMZELX may increase your risk of having serious side effects, including:

Indication: BIMZELX® is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet light alone or with pills (phototherapy).

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about BIMZELX® (bimekizumab-bkzx)?

BIMZELX is a medicine that affects your immune system. BIMZELX may increase your risk of having serious side effects, including:

  • Suicidal thoughts and behavior have happened in some people treated with BIMZELX. Get medical help right away or call the National Suicide and Crisis Lifeline at 988 if you, your caregiver or your family member notice in you any of the following symptoms:
    • new or worsening depression or anxiety
    • thoughts of suicide, dying, or hurting yourself
    • changes in behavior or mood
    • acting on dangerous impulses
    • attempt to commit suicide
  • Infections. BIMZELX is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections.
    • Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with BIMZELX.
    • If your healthcare provider feels you are at risk for TB, you may be treated with medicine for TB before you begin treatment with BIMZELX and during your treatment.
    • Your doctor should watch you closely for signs and symptoms of TB during and after treatment with BIMZELX. Do not take BIMZELX if you have an active TB infection.

Before starting BIMZELX, tell your healthcare provider if you:

  • are being treated for an infection
  • have an infection that does not go away or that keeps coming back
  • have TB or have been in close contact with someone with TB
  • think you have an infection or have symptoms of an infection such as:
    • fever, sweats, or chills
    • muscle aches
    • cough
    • shortness of breath
    • blood in your phlegm
    • weight loss
    • warm, red, or painful skin or sores on your body different from your psoriasis
    • diarrhea or stomach pain
    • burning when you urinate or urinating more often than normal

After starting BIMZELX, call your healthcare provider right away if you have any of the signs of infection listed above. Do not use BIMZELX if you have any signs of infection unless you are instructed to by your healthcare provider. See “What are the possible side effects of BIMZELX?” for more information about side effects.

What is BIMZELX?

BIMZELX is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet light alone or with pills (phototherapy).

  • It is not known if BIMZELX is safe and effective in children.

Before using BIMZELX, tell your healthcare provider about all of your medical conditions, including if you:

  • have any of the conditions or symptoms listed in the section “What is the most important information I should know about BIMZELX?”
  • have a history of depression, or suicidal thoughts or behavior
  • have liver problems
  • have inflammatory bowel disease (Crohn’s disease or ulcerative colitis)
  • have recently received or are scheduled to receive an immunization (vaccine). You should avoid receiving live vaccines during treatment with BIMZELX.
  • are pregnant or plan to become pregnant. It is not known if BIMZELX can harm your unborn baby.
    • If you become pregnant while taking BIMZELX, you are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-311-8972 to enroll in this registry or visit http://mothertobaby.org/pregnancy-studies/.
  • are breastfeeding or plan to breastfeed. It is not known if BIMZELX passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with BIMZELX.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

What are the possible side effects of BIMZELX?

BIMZELX may cause serious side effects. See “What is important information I should know about BIMZELX?”

  • Elevated liver enzyme levels. Your healthcare provider will do blood tests to check your liver enzyme levels before starting treatment and during treatment with BIMZELX. Your healthcare provider may temporarily stop or permanently stop your treatment with BIMZELX if you develop liver problems. Call your healthcare provider right away if you develop any signs or symptoms of liver problems, including:
    • pain on the right side of your stomach-area
    • feeling very tired
    • loss of appetite
    • nausea and vomiting
    • itching
    • dark urine
    • light-colored stool
    • yellowing of your skin or the whites of your eyes
  • Inflammatory bowel disease. New cases of inflammatory bowel disease or “flare-ups” have happened with BIMZELX. If you have inflammatory bowel disease (Crohn’s disease or ulcerative colitis), tell your healthcare provider if you have worsening disease symptoms during treatment with BIMZELX or develop new or worsening signs of Crohn’s disease or ulcerative colitis.

The most common side effects of BIMZELX include:

  • upper respiratory tract infections
  • headache
  • herpes simplex infections (cold sores in or around the mouth)
  • small red bumps on your skin
  • feeling tired
  • fungal infections (oral thrush or infections in the mouth, throat, skin, nails, feet, or genitals)
  • pain, redness, or swelling at the injection site
  • stomach flu (gastroenteritis)
  • acne

These are not all of the possible side effects of BIMZELX. Call your doctor for medical advice about side effects.

Use BIMZELX exactly as your doctor tells you to use it.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.